SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 102 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,289,000 | +508.8% | 152,817 | +395.0% | 0.08% | +581.8% |
| Q1 2016 | $376,000 | -89.0% | 30,872 | -78.1% | 0.01% | -88.2% |
| Q2 2015 | $3,420,000 | +116.5% | 140,684 | +107.0% | 0.09% | +132.5% |
| Q1 2015 | $1,580,000 | -54.0% | 67,954 | -50.1% | 0.04% | -47.4% |
| Q4 2014 | $3,433,000 | +56.2% | 136,149 | +92.6% | 0.08% | +52.0% |
| Q3 2014 | $2,198,000 | +0.6% | 70,683 | -16.8% | 0.05% | -29.6% |
| Q2 2014 | $2,184,000 | -30.6% | 84,968 | -31.5% | 0.07% | -10.1% |
| Q4 2013 | $3,149,000 | -41.2% | 124,065 | -52.7% | 0.08% | -33.6% |
| Q3 2013 | $5,353,000 | +638.3% | 262,408 | +659.7% | 0.12% | +495.0% |
| Q2 2013 | $725,000 | – | 34,542 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |